Gilles Pelletier

3.1k total citations
45 papers, 2.2k citations indexed

About

Gilles Pelletier is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gilles Pelletier has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 15 papers in Hepatology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gilles Pelletier's work include Gallbladder and Bile Duct Disorders (12 papers), Liver Disease and Transplantation (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Gilles Pelletier is often cited by papers focused on Gallbladder and Bile Duct Disorders (12 papers), Liver Disease and Transplantation (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Gilles Pelletier collaborates with scholars based in France, Belgium and Switzerland. Gilles Pelletier's co-authors include Catherine Buffet, Frédéric Prat, Jacques Fritsch, J P Etienne, André Daniel Choury, P Attali, B. Ducot, Alain Roche, Philippe Rougier and Olivier Ink and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer.

In The Last Decade

Gilles Pelletier

43 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilles Pelletier France 21 1.1k 1.1k 902 634 487 45 2.2k
Catherine Buffet France 24 1.2k 1.0× 1.5k 1.4× 823 0.9× 1.5k 2.3× 528 1.1× 76 3.1k
S T Fan China 25 1.0k 0.9× 1.0k 0.9× 454 0.5× 664 1.0× 522 1.1× 53 1.9k
Umberto Baccarani Italy 32 1.8k 1.6× 1.5k 1.4× 468 0.5× 795 1.3× 513 1.1× 193 3.1k
Bertrand Suc France 27 1.9k 1.6× 757 0.7× 886 1.0× 538 0.8× 1.3k 2.7× 97 2.8k
Sang Ok Kwon South Korea 29 1.0k 0.9× 1.3k 1.2× 427 0.5× 1.2k 1.8× 242 0.5× 88 2.3k
Mark Wilkinson United Kingdom 20 1.1k 1.0× 737 0.7× 979 1.1× 488 0.8× 602 1.2× 74 2.1k
P-A Clavien Switzerland 24 1.2k 1.1× 493 0.5× 584 0.6× 268 0.4× 315 0.6× 35 1.7k
Juan Figueras Spain 28 2.1k 1.8× 2.2k 2.1× 481 0.5× 783 1.2× 717 1.5× 89 3.2k
Fabrizio Panaro France 26 1.3k 1.1× 893 0.8× 395 0.4× 463 0.7× 523 1.1× 159 2.0k
Alexander Dechêne Germany 22 691 0.6× 868 0.8× 413 0.5× 822 1.3× 181 0.4× 71 1.7k

Countries citing papers authored by Gilles Pelletier

Since Specialization
Citations

This map shows the geographic impact of Gilles Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Pelletier more than expected).

Fields of papers citing papers by Gilles Pelletier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Pelletier. The network helps show where Gilles Pelletier may publish in the future.

Co-authorship network of co-authors of Gilles Pelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Pelletier. A scholar is included among the top collaborators of Gilles Pelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Pelletier. Gilles Pelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamdi‐Rozé, Houda, Séverine Cunat, V. Loustaud‐Ratti, et al.. (2021). A simple clinical score to promote and enhance ferroportin disease screening. Journal of Hepatology. 76(3). 568–576. 5 indexed citations
2.
Hamdi‐Rozé, Houda, Martine Ropert, Lénaı̈ck Détivaud, et al.. (2018). Variable expressivity of HJV related hemochromatosis: “Juvenile” hemochromatosis?. Blood Cells Molecules and Diseases. 74. 30–33. 10 indexed citations
3.
Merle, Philippe, Philippe Camus, Armand Abergel, et al.. (2017). Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma. ESMO Open. 2(4). e000238–e000238. 36 indexed citations
4.
Bhangui, Prashant, Marc‐Antoine Allard, Éric Vibert, et al.. (2015). Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma. Annals of Surgery. 264(1). 155–163. 84 indexed citations
5.
Faitot, François, Marc‐Antoine Allard, Gabriella Pittau, et al.. (2015). Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation. Hepatology. 62(1). 179–187. 36 indexed citations
6.
Pelletier, Gilles. (2010). La population du Québec par territoire des centres locaux de services communautaires, par territoire des réseaux locaux de services et par région sociosanitaire de 1981 à 2031 [ressource électronique] / [recherche et rédaction, Gilles Pelletier, Nadia Kammoun]. 9 indexed citations
7.
Vienne, Ariane, H. Gouya, Nathanaël Lapidus, et al.. (2010). Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointestinal Endoscopy. 72(4). 728–735. 193 indexed citations
8.
Cénée, Sylvie, Pierre Laurent‐Puig, Marie‐Anne Loriot, et al.. (2008). Hepatocellular Carcinoma and Occupation in Men: A Case-Control Study. Journal of Occupational and Environmental Medicine. 50(2). 212–220. 6 indexed citations
9.
Zidi, S H, David Zanditenas, Moana Gelu‐Siméon, et al.. (2007). Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts. Liver International. 27(10). 1389–1393. 30 indexed citations
10.
Pelletier, Gilles. (2007). Physiopathologie des diarrhées tropicales. La Presse Médicale. 36(4). 687–693. 1 indexed citations
11.
12.
Prat, Frédéric, Juan Amaris, B. Ducot, et al.. (2002). Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study. Gastrointestinal Endoscopy. 56(2). 202–208. 81 indexed citations
13.
Prat, Frédéric, et al.. (2002). Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study. Gastrointestinal Endoscopy. 56(6). 909–915. 12 indexed citations
14.
Prat, Frédéric, Cyril Lafon, Jacques Fritsch, et al.. (2002). Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study. Gastrointestinal Endoscopy. 56(6). 909–915. 45 indexed citations
15.
Amaris, Juan, et al.. (2002). Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study. Gastrointestinal Endoscopy. 56(2). 202–208. 10 indexed citations
16.
Prat, Frédéric, et al.. (1999). Prediction of Common Bile Duct Stones by Noninvasive Tests. Annals of Surgery. 229(3). 362–368. 90 indexed citations
17.
Pelletier, Gilles, Michel Ducreux, France Gay, et al.. (1998). Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Journal of Hepatology. 29(1). 129–134. 302 indexed citations
18.
Pelletier, Gilles, et al.. (1992). Impaired functions of normal peripheral polymorphonuclear leukocytes in cirrhotic ascitic fluid. Journal of Hepatology. 16(1-2). 98–101. 12 indexed citations
19.
Cadranel, Jean–François, Jacques Cadranel, Catherine Buffet, et al.. (1990). Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis. Gastroenterology. 99(1). 268–273. 4 indexed citations
20.
Cadranel, Jean–François, Jacques Cadranel, Catherine Buffet, et al.. (1990). Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis. Gastroenterology. 99(1). 268–273. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Buffet Breakdown of academic impact, for papers by S T Fan Breakdown of academic impact, for papers by Umberto Baccarani Breakdown of academic impact, for papers by Bertrand Suc Breakdown of academic impact, for papers by Sang Ok Kwon Breakdown of academic impact, for papers by Mark Wilkinson Breakdown of academic impact, for papers by P-A Clavien Breakdown of academic impact, for papers by Juan Figueras Breakdown of academic impact, for papers by Fabrizio Panaro Breakdown of academic impact, for papers by Alexander Dechêne
Rankless by CCL
2026